IP Library Granted Patent US 7,947,723
Granted Patent B2
US 7,947,723 · App. 12/363,168 · Granted May 24, 2011

Synthesis and anti-proliferative effect of benzimidazole derivatives

Assignee: Spelman College
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,947,723
App. No.
12/363,168
Granted
May 24, 2011
Kind
B2
Abstract

This invention provides for compounds, compositions, and methods that involve anti-proliferative and anti-neoplastic activity in cancer cells. In particular, a series of benzimidazole, purine, imidazopyridine, and imidazopyrizine compounds having selected substitution patterns are disclosed, and the activity of various subject compounds is demonstrated. For example, the invention provides compounds having the general formula: their pharmaceutical compositions, and methods of treatment using the subject compounds and compositions.

Claims (17)

1. A compound having the formula:

wherein J is selected from

wherein Z is selected from CH 2 , NH, O, or S;

wherein Q is selected from CH 2 , NH, O, or S;

wherein n is 1, 2, or 3; or

wherein X in each occurrence is selected from hydrogen; a halide; a linear or branched alkyl having up to 10 carbon atoms, optionally substituted with at least one halide; or an alkoxide having a linear or branched alkyl group having up to 10 carbon atoms, optionally substituted with at least one halide;

wherein X D is selected from

and Y is selected from O or NH.

2. A compound according to claim 1 , having the formula:

wherein X is selected from hydrogen; a halide; a linear or branched alkyl having up to 10 carbon atoms, optionally substituted with at least one halide; or an alkoxide having a linear or branched alkyl group having up to 10 carbon atoms, optionally substituted with at least one halide; and Y is selected from O or NH.

3. A compound according to claim 1 having the formula:

wherein J is selected from

wherein X is selected from CH 3 , C(CH 3 ) 3 , or OCH 3 ;

wherein Z is selected from CH 2 , NH, O, or S;

wherein Q is selected from CH 2 , NH, O, or S; or

wherein n is 1, 2, or 3; and Y is selected from O or NH.

4. A pharmaceutical composition comprising a therapeutically-effective amount of at least one compound according to claim 1 or a pharmaceutically-acceptable salt thereof, and a pharmaceutically-acceptable carrier.

Assignments (2)
CONFIRMATORY LICENSE Recorded Mar 29, 2012
From: SPELMAN COLLEGE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 027956/0684 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2009
From: WINFIELD, LEYTE L.
To: SPELMAN COLLEGE
Reel/Frame 022182/0923 →
Continuity (2)
Provisional Application 61025462 · Feb 1, 2008
Related Publication 20090197889A1 · Aug 6, 2009